Scientists hunt for hidden ARDS subtypes to crack deadly lung failure

NCT ID NCT07633366

Recruiting now Knowledge-focused Sponsor: Medical University of Vienna Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study will analyze samples from 130 ICU patients with ARDS (a severe lung injury) to better understand why the condition varies so much between people. Researchers will examine lung fluid, blood, and CT scans to identify distinct biological subtypes. The goal is not to test a new drug, but to uncover clues that could lead to more personalized treatments in the future.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could reveal distinct ARDS subtypes, paving the way for more targeted treatments and better diagnostic markers in the future.
What could go wrong: This is an observational study, not a treatment trial. It aims to generate hypotheses, not test a therapy, so direct patient benefits are not immediate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARDS (ACUTE RESPIRATORY DISTRESS SYNDROME) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute lung injury acute respiratory distress syndrome coinfection COVID-19 influenza pneumonia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARDS (ACUTE RESPIRATORY DISTRESS SYNDROME)

Contacts and locations

Locations

General Hospital of Vienna, Medical University of Vienna
RECRUITING

Vienna, State of Vienna, 1090, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.